Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic (Q29585)

From lgbtDB
Jump to navigation Jump to search
No description defined
  • Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic.
Language Label Description Also known as
English
Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic
No description defined
  • Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic.

Statements

title
Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic. (English)
1 reference
stated in
PubMed
abstract
There is very little information on the experiences of transgender and gender diverse (TGD) youth with cancer. (English)
source label
BACKGROUND (English)
subsection NLM category
background section
series ordinal
1
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
To examine clinical characteristics and care trajectories of TGD youth a history of cancer. (English)
source label
AIMS (English)
subsection NLM category
objective section
series ordinal
2
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
This case series reviewed records of 2790 pediatric gender clinic patients seen between 2007 and 2022 to identify 14 with a history of cancer diagnosis. (English)
source label
METHODS (English)
subsection NLM category
methods section
series ordinal
3
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
Demographics, clinical characteristics, disclosure of gender identity to oncology teams, oncology teams' use of correct names and pronouns, documented interprofessional communication between gender health and oncology teams, and course of medical gender affirmation were reviewed. (English)
source label
METHODS (English)
subsection NLM category
methods section
series ordinal
4
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
Of 14 TGD youth with a history of cancer, 11 (78.6%) were diagnosed prior to presenting to the gender clinic (mean [SD] = 8.2 [4.7] years), three following initial gender care (mean [SD] = 1.1 [0.2] years). (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
5
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
Six (42.9%) patients were engaged in annual survivorship care when presenting, and 8 (57.1%) were seen concurrently by both clinics. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
6
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
Nine (64.3%) patients had documented communication between teams. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
7
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
Three-quarters of patients who were seen concurrently by both clinics had documented interprofessional communication. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
8
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
Eight (57.1%) patients received gender affirming hormones, after cancer treatment concluded. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
9
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
TGD youth with cancer experiences present for gender affirming care and merit clinical attention. (English)
source label
CONCLUSION (English)
subsection NLM category
conclusion section
series ordinal
10
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
There was variability in (1) patients' and families' disclosure of TGD identities to oncology teams, (2) whether oncology documentation consistently used patients' correct name and pronouns, and (3) whether there was documented interprofessional consultation between teams. (English)
source label
CONCLUSION (English)
subsection NLM category
conclusion section
series ordinal
11
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
There is need for ongoing improvement in research and clinical protocols for TGD youth with cancer. (English)
source label
CONCLUSION (English)
subsection NLM category
conclusion section
series ordinal
12
copyright statement
© 2024 John Wiley & Sons Ltd. (English)
date copyrighted
2024
rights holder
John Wiley & Sons
1 reference
stated in
PubMed
date published
November 2024
1 reference
stated in
PubMed
date issued
November 2024
1 reference
stated in
PubMed
author
volume
33
1 reference
stated in
PubMed
issue
11
1 reference
stated in
PubMed
page(s)
e70017
1 reference
stated in
PubMed
page start
e70017
1 reference
stated in
PubMed
date of article
unknown value
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q29585&oldid=181250"